CIAS
FLNA

Capital Investment Advisory Services’s Filana Therapeutics FLNA Stock Holding History

Capital Investment Advisory Services’s Portfolio FLNA Stock Details FLNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-17,874
Closed -$526K – 994
2024
Q3 		$526K Sell
17,874
-2,526
-12% -$58.2K 0.05% 287
2024
Q2 		$252K Buy
+20,400
New +$430K 0.03% 437

Other funds holding FLNA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
National Bank of Canada
National Bank of Canada Montreal, Quebec, Canada $112B AUM 31.26% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return

Capital Investment Advisory Services's FLNA Position: Q4 2024 in Review

Capital Investment Advisory Services sold out of Filana Therapeutics (FLNA) in Q4 2024, closing a stake of 17,874 shares — an estimated $526K sold.

Capital Investment Advisory Services first reported a position in FLNA in Q2 2024 and held it in 2 quarters. The position peaked at $526K in Q3 2024. 137 funds tracked by Wall St. Rank hold FLNA as of Q4 2024.

  • Capital Investment Advisory Services reported no remaining Filana Therapeutics position as of Q4 2024 after selling out during the quarter.
  • Capital Investment Advisory Services sold 17,874 Filana Therapeutics shares in Q4 2024, an estimated $526K.
  • Capital Investment Advisory Services first reported a position in Filana Therapeutics in Q2 2024 and held it in 2 quarters.
  • Capital Investment Advisory Services's Filana Therapeutics position peaked at $526K in Q3 2024.
  • 137 funds tracked by Wall St. Rank held Filana Therapeutics as of Q4 2024.

Based on Capital Investment Advisory Services's 13F filing for Q4 2024, filed 23 Jan 2025.